64 related articles for article (PubMed ID: 8135497)
21. The effect of acute hypercalcaemia on arginine induced growth hormone release in diabetic man.
Kaplan PW; Jung RT
Horm Metab Res; 1984 Dec; 16 Suppl 1():123-6. PubMed ID: 6532933
[TBL] [Abstract][Full Text] [Related]
22. [The pancreatic reserve in diabetes mellitus by the determination of serum C-peptide using radioimmunoassay].
Arteaga A; Velasco N; Szegedi AM; Pellegrino MR; López G; Foradori A; Acosta AM
Rev Med Chil; 1984 Apr; 112(4):321-9. PubMed ID: 6385178
[No Abstract] [Full Text] [Related]
23. [The insulin, C-peptide and glucagon content of the blood of patients with chronic opisthorchiasis].
Lepekhin AV; Milevskaia SG; Kiselev VP; Stepanova TF; Ruzaeva LA
Med Parazitol (Mosk); 1990; (6):48-9. PubMed ID: 2290401
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes.
Basso D; Plebani M; Fogar P; Panozzo MP; Meggiato T; De Paoli M; Del Favero G
Int J Clin Lab Res; 1995; 25(1):40-3. PubMed ID: 7787209
[TBL] [Abstract][Full Text] [Related]
25. [Pancreatic hormones and cyclic nucleotides in the blood in chronic recurrent pancreatitis].
Iagoda AV; Mosin VI
Ter Arkh; 1984; 56(12):94-6. PubMed ID: 6151752
[TBL] [Abstract][Full Text] [Related]
26. [Pancreatic function of chronic pancreatitis patients].
Vakhrushev IaM; Trusov VV; Solov'eva NE
Klin Med (Mosk); 1987 Sep; 65(9):88-91. PubMed ID: 3320500
[No Abstract] [Full Text] [Related]
27. [Insulin, glucagon and plasmatic somatotropic hormone in 5 cases of extra-pancreatic hypoglycemizing tumors. Review of the literature].
Rosselin G; Assan R; Freychet P; Dolais J; Tchobroutsky G
Presse Med (1893); 1967 Apr; 75(21):1045-50. PubMed ID: 6024352
[No Abstract] [Full Text] [Related]
28. [Circulating types of human glucagon (author's transl)].
Valverde I
MMW Munch Med Wochenschr; 1978 Mar; 120(12):407-9. PubMed ID: 306029
[TBL] [Abstract][Full Text] [Related]
29. [Influence of renal function on the kinetics of pancreatic hormones in chronic renal disorders (author's transl)].
Kanno R
Nihon Jinzo Gakkai Shi; 1978 Feb; 20(2):137-50. PubMed ID: 671843
[No Abstract] [Full Text] [Related]
30. [Clinical studies of pancreatic endocrine function in liver cirrhosis].
Chiba T; Kondo T; Nakayama K; Yamazoe A; Fukami T
Horumon To Rinsho; 1977 May; 25(5):545-9. PubMed ID: 560264
[No Abstract] [Full Text] [Related]
31. Beta-cell function in pancreatic adenocarcinoma.
Basso D; Plebani M; Fogar P; Del Favero G; Briani G; Meggiato T; Panozzo MP; Ferrara C; D'Angeli F; Burlina A
Pancreas; 1994 May; 9(3):332-5. PubMed ID: 8022755
[TBL] [Abstract][Full Text] [Related]
32. [Radioimmunologic determination of gastrin, insulin, C-peptide, glucagon and trypsin in the combined radiotherapy of cervix cancer].
Modnikov OP
Lab Delo; 1984; (6):358-60. PubMed ID: 6206290
[No Abstract] [Full Text] [Related]
33. [Incretory changes in the pancreatic hormones in chronic pancreatitis].
Iakhontova OI; Zaĭchik AM; Pomazovskaia A
Ter Arkh; 1986; 58(12):97-9. PubMed ID: 3824227
[TBL] [Abstract][Full Text] [Related]
34. Congenital pancreatic hypoplasia: a syndrome of exocrine and endocrine pancreatic insufficiency.
Winter WE; Maclaren NK; Riley WJ; Toskes PP; Andres J; Rosenbloom AL
J Pediatr; 1986 Sep; 109(3):465-8. PubMed ID: 3746536
[TBL] [Abstract][Full Text] [Related]
35. [Secretion of enteroglucagon in patients following total duodenopancreatectomy].
Thiel M; Krause U; Mangold G; Wolf E; Beyer J
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1399-403. PubMed ID: 611852
[No Abstract] [Full Text] [Related]
36. Prospective evaluation of some candidate tumor markers in the diagnosis of pancreatic cancer.
Mackie CR; Moossa AR; Go VL; Noble G; Sizemore G; Cooper MJ; Wood RA; Hall AW; Waldmann T; Gelder F; Rubenstein AH
Dig Dis Sci; 1980 Mar; 25(3):161-72. PubMed ID: 6989572
[TBL] [Abstract][Full Text] [Related]
37. Short-term changes in pancreatic α-cell function after the onset of fulminant type 1 diabetes.
Takahashi N; Chujo D; Tsujimoto T; Kajio H
J Diabetes Investig; 2018 May; 9(3):636-637. PubMed ID: 29750106
[No Abstract] [Full Text] [Related]
38. Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide.
Basso D; Valerio A; Seraglia R; Mazza S; Piva MG; Greco E; Fogar P; Gallo N; Pedrazzoli S; Tiengo A; Plebani M
Pancreas; 2002 Jan; 24(1):8-14. PubMed ID: 11741177
[TBL] [Abstract][Full Text] [Related]
39. [C-peptide and the importance of its determination].
Perusicová J; Skachová J
Vnitr Lek; 1986 Jun; 32(6):587-91. PubMed ID: 3739250
[No Abstract] [Full Text] [Related]
40. Pancreatic A-cell tumor associated with severe diabetes mellitus.
Yoshinaga T; Okuno G; Shinji Y; Tsujii T; Nishikawa M
Diabetes; 1966 Oct; 15(10):709-13. PubMed ID: 5924832
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
